Newsbenzinga
Weight Loss Drug: Viking Therapeutics Says Lead Obesity Drug Shows Weight Retention with Less Frequent Dosing
· Published
Article summary
Viking Therapeutics reports positive VK2735 study results showing effective weight maintenance with monthly and biweekly dosing regimens.
An excerpt from the original article.
Comments —
Loading comments…